Regeneron Pharmaceuticals
REGN
REGN
1,383 hedge funds and large institutions have $97.3B invested in Regeneron Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 140 funds opening new positions, 538 increasing their positions, 460 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $98.8B → $97.3B (-$1.46B)
21% less funds holding in top 10
Funds holding in top 10: 29 → 23 (-6)
22% less call options, than puts
Call options by funds: $1.41B | Put options by funds: $1.8B
Holders
1,383
Holding in Top 10
23
Calls
$1.41B
Puts
$1.8B
Top Buyers
| 1 | +$979M | |
| 2 | +$381M | |
| 3 | +$363M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$272M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$236M |
Top Sellers
| 1 | -$877M | |
| 2 | -$691M | |
| 3 | -$379M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$319M |
| 5 |
Morgan Stanley
New York
|
-$173M |